Tumor-specific suppressor T-cells which inhibit the in vitro generation of cytolytic T-cells from immune and early tumor-bearing host spleens.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Cancer Research

• Publication date

  1986-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2936451
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of antitumor immunity — Immunobiologic approaches

  2004cited by this paper
• Regulation of the immune response to antigens on the malignant cell surface

  2004cited by this paper
• Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells

  1984cited by this paper
• Suppressor cells and immunoregulation.

  1984cited by this paper
• Summary: potential of interleukin-2 for the therapy of cancer.

  1984cited by this paper
• Regulation of the immune response to tumor antigens. X. Activation of third-order suppressor T cells that abrogate anti-tumor immune responses.

  1984cited by this paper
• Suppressor T cells and the immune response to tumors.

  1984cited by this paper
• Specificity of the T Cells That Mediate and Suppress Adoptive Immunotherapy of Established Tumors

  1984cited by this paper
• Immunotherapy of cancer by systemic administration of lymphoid cells plus interleukin-2.

  1984cited by this paper
• Heterogeneity of natural killer cells.

  1984cited by this paper
• Variation in selectivity of tumor cell cytolysis by murine macrophages, macrophage‐like cell lines and NK cells

  1982cited by this paper
• Suppressor T cells and the regression phase of syngeneic intradermally developing p-815 mastocytomas.

  1982cited by this paper
• Mechanisms of anti-tumor action of Corynebacterium parvum. II. Potentiated cytolytic T cell response and its tumor-induced suppression

  1981cited by this paper
• T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P815 mastocytoma and its metastases

  1981cited by this paper
• Stimulation of cytolytic T lymphocytes by azaguanine-resistant mouse tumor cells in selective HAT medium.

  1981cited by this paper
• T cell subset interactions in the regulation of syngeneic tumor immunity.

  1981cited by this paper
• Correlation of in vivo and in vitro immune reactions against the intradermally developing P-815 mastocytoma in the syngeneic mouse.

  1980cited by this paper
• T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor

  1980cited by this paper
• Differential activation of cytotoxic and suppressor T cells against syngeneic tumors in the mouse.

  1979cited by this paper
• Xenogeneic Monoclonal Antibodies to Mouse Lymphoid Differentiation Antigens *

  1979cited by this paper
• A functional comparison of tumor cell killing by activated macrophages and natural killer cells

  1979cited by this paper
• Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.

  1979cited by this paper
• "Panning" for lymphocytes: a method for cell selection.

  1978cited by this paper
• Regulation of the immune response to tumor antigen. VI. Differential specificities of suppressor T cells or their products and effector T cells.

  1978cited by this paper
• Cellular interaction between cytotoxic and suppressor T cells against syngeneic tumors in the mouse.

  1978cited by this paper
• Regulation of the immune response to tumor antigen. IV. Tumor antigen-specific suppressor factor(s) bear I-J determinants and induce suppressor T cells in vivo.

  1978cited by this paper
• Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts.

  1977cited by this paper
• Characterization of suppressor cells in mice bearing syngeneic mastocytoma.

  1977cited by this paper
• Immunotherapy of cancer.

  1977cited by this paper
• Immunosuppression and the role of suppressive factors in cancer.

  1977cited by this paper
• Mouse lymphocytes with and without surface immunoglobulin: preparative scale separation in polystyrene tissue culture dishes coated with specifically purified anti-immunoglobulin.

  1977cited by this paper
• In vitro induction of cytotoxicity against syngeneic mastocytoma and its suppression by spleen and thymus cells from tumor-bearing mice.

  1976cited by this paper
• Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts.

  1976cited by this paper
• Prospects for the immunotherapy of cancer. Part II: current status of immunotherapy.

  1975cited by this paper

• Implications of regulatory T cells in anti-cancer immunity: from pathogenesis to therapeutics

  2022cites this paper
• Biological activity of 4-ethynyl-, 4-oxy-, 4-butoxypropylpyperidine and azaheterocyclic compounds

  2021cites this paper
• Immunoenhancement effects of pentadecapeptide derived from Cyclina sinensis on immune-deficient mice induced by Cyclophosphamide

  2019cites this paper
• Immune-enhancing effects of anionic macromolecules extracted from Codium fragile on cyclophosphamide-treated mice

  2019cites this paper
• Fermented Red Ginseng Alleviates Cyclophosphamide-Induced Immunosuppression and 2,4,6-Trinitrobenzenesulfonic Acid-Induced Colitis in Mice by Regulating Macrophage Activation and T Cell Differentiation.

  2018cites this paper
• Oral administration of tea saponins to relive oxidative stress and immune suppression in chickens

  2017cites this paper
• Pleurotus nebrodensis polysaccharide (PN-S) enhances the immunity of immunosuppressed mice.

  2015cites this paper
• Immune-enhancing activity of polysaccharides from Cyrtomium macrophyllum.

  2014cites this paper
• Immuno-enhancement effects of ethanol extract from Cyrtomium macrophyllum (Makino) Tagawa on cyclophosphamide-induced immunosuppression in BALB/c mice.

  2014cites this paper
• Lactobacillus plantarum HY7712 ameliorates cyclophosphamide-induced immunosuppression in mice.

  2013cites this paper
• Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice.

  2012cites this paper
• Promotion of Myelopoiesis in Myelosuppressed Mice by Ganoderma lucidum Polysaccharides

  2012cites this paper
• The Antitumor and Immunostimulating Activities of Water Soluble Polysaccharides from Radix Aconiti, Radix Aconiti Lateralis and Radix Aconiti Kusnezoffii

  2010cites this paper
• Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice.

  2009cites this paper
• Combined effect of cisplatin and lymphokine-activated killer cells on A549 cells of non-small cell lung cancer

  2007cites this paper
• Ganoderma lucidum polysaccharides enhance the function of immunological effector cells in immunosuppressed mice.

  2007cites this paper
• Suppression of anti-cancer immunity by regulatory T cells: back to the future.

  2006cites this paper
• Activation and expansion of cytotoxic T lymphocytes from tumor-draining lymph nodes

  2005cites this paper
• Cyclophosphamide and abrogation of tumor-induced suppressor T cell activity

  2005influential citation
• Synergistic antitumor activity of cyclophosphamide and ABPP in the treatment of established and advanced tumors in murine tumor models

  2004cites this paper
• In vitro expression of secondary antitumor immunity by in vivo tumor-sensitized T cells: Inhibition by tumor-induced suppressor T cells

  2004cites this paper
• Trafficking of ‘immune’ CD4+/CD8+ T-lymphocytes into the RENCA tumour microcirculation in vivo in mice

  2000cites this paper
• Combination Effects of Gene Modified Tumor Cell Vaccines and Chemotherapy

  1999cites this paper
• Enhanced antitumor immune responses of IL-2 gene-modified tumor vaccine by combination with IL-1 and low dose cyclophosphamide.

  1999cites this paper
• Immunotherapy of established tumors in mice by intratumoral injection of interleukin-2 plasmid DNA: induction of CD8+ T-cell immunity.

  1998cites this paper
• Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors.

  1996cites this paper
• Bryostatin 1 activates splenic lymphocytes and induces sustained depletion of splenocyte protein kinase C activity in vivo after a single intravenous administration

  1996cites this paper
• Causes of immunosuppression in squamous cell carcinoma of the head and neck.

  1996cites this paper
• Grundlagen immunologischer Vorgänge beim Plattenepithelkarzinom im Kopf-Hals-Bereich — Diagnostik und Ursachen

  1995cites this paper
• Abrogation of suppressor cells activity by cis-diamminedichloroplatinum (CDDP) treatment using therapeutic doses in ovarian cancer patients.

  1994cites this paper
• Generation of Specific Antitumor Cytotoxic T-Lymphocytes in Monoculture can be Inhibited by T-Suppressors from Tumor-Bearing Mice

  1994cites this paper
• Effect of murine interferon α/β on tumor-induced suppressor function

  1994cites this paper
• Effect of murine interferon alpha/beta on tumour-induced suppressor function.

  1994cites this paper
• Generation of cytotoxic T lymphocytes from peripheral blood.

  1993cites this paper
• Presence of CD4+ T suppressor cells in mice rendered unresponsive to tumor antigens by intravenous injection of irradiated tumor cells

  1993cites this paper
• Serum concentrations of immune parameters during acute cardiogenic pulmonary edema

  1992cites this paper
• Tumor-infiltrating lymphocytes. Potential and limitations to their use for cancer therapy.

  1992cites this paper
• Tumor-infiltrating lymphocytes

  1992cites this paper
• Formation of specific antitumor cytotoxic T lymphocytes in monoculture

  1992cites this paper
• Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide

  1992influential citation
• Suppressor T cells of tumor-bearing mice inhibit antitumor cytotoxic T lymphocyte maturation in monoculture

  1992cites this paper
• Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.

  1992cites this paper
• Activation and in vitro expansion of tumor‐reactive T Lymphocytes from lymph nodes draining human primary breast cancers

  1991cites this paper
• A cytotoxic T-lymphocyte clone derived from mice with progressively growing tumors.

  1991cites this paper
• Myelopoiesis-associated suppressor-cell activity in mice with Lewis lung carcinoma tumors: interferon-gamma plus tumor necrosis factor-alpha synergistically reduce suppressor cell activity.

  1990cites this paper
• Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia.

  1990cites this paper
• Local immune reaction in syngeneic mice against tumorigenic and nontumorigenic BPV‐transformed mouse cell lines

  1990cites this paper
• Induction of endogenous lymphokine-activated killer activity by combined administration of lentinan and interleukin 2.

  1990cites this paper
• Immunosuppression in murine renal cell carcinoma

  1990cites this paper
• Immunosuppression and Human Malignancy

  1990cites this paper
• Immunosuppression in murine renal cell carcinoma

  1990cites this paper
• Myelopoiesis‐associated suppressor‐cell activity in mice with lewis lung carcinoma tumors: Interferon‐γ plus tumor necrosis factor‐α synergistically reduce suppressor cell activity

  1990cites this paper
• The absence of lymphoid suppressor cells in tumor-involved lymph nodes of patients with head and neck cancer.

  1990cites this paper
• Selenium and the Immune Response: 2. Enhancement of Murine Cytotoxic T‐Lymphocyte and Natural Killer Cell Cytotoxicity In Vivo

  1989cites this paper
• Changes of peripheral t‐cell subsets in asplenic w256 tumor‐bearing rats

  1989cites this paper
• Immune Response against P815X2 Mastocytoma Growing in Syngeneic DBA/2 Mice

  1989cites this paper
• Increased serum CD8 antigen level in childhood Hodgkin's disease relates to advanced stage and poor treatment outcome.

  1989cites this paper
• Effects of fish oil and corn oil diets on prostaglandin-dependent and myelopoiesis-associated immune suppressor mechanisms of mice bearing metastatic Lewis lung carcinoma tumors.

  1989cites this paper
• Selenium and the Immune Response: 1. Modulation of Alloreactive Human Lymphocyte Functions In Vitro

  1989cites this paper
• in vitro proliferative responses of spleen lymphocytes from rats bearing progressive or regressive tumors induced by cell variants of a syngeneic colon carcinoma

  1989cites this paper
• Evolution of tumours attacked by immune cytotoxic cells: The immune response dilemma

  1989cites this paper
• T-cell subsets of peripheral blood and spleen in hepatocarcinoma-bearing rats

  1989cites this paper
• Phenotype of syngeneic tumor-specific cytotoxic T-lymphocytes and requirements for their in vitro generation from tumor-bearing host and immune spleens.

  1988cites this paper
• Serum levels of CD8 antigen in childhood lymphoid malignancies: a possible indicator of increased suppressor cell activity in poor-risk patients.

  1988cites this paper
• Humoral mechanism of inhibition of immunoreactivity of mouse lymphocytes in vitro by mastocytoma P815 cells

  1988cites this paper
• Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.

  1988cites this paper
• The effect of recombinant murine interferon-gamma on the hematopoietic and immunological parameters of mice bearing metastatic Lewis lung carcinoma tumors.

  1988cites this paper
• Production of tumor-specific suppressor T cell hybridomas.

  1987cites this paper
• Evasion of host defences by tumours

  1987cites this paper
• Lactate dehydrogenase in rat mitochondria.

  1987cites this paper
• 5'-structural analysis of genes encoding polymorphic antigens of chemically induced tumors.

  1987cites this paper
• Immunotherapy of pulmonary metastases using monoclonal antibody to T-cell suppressor factor and interleukin 2.

  1987cites this paper